Investing Profile

Daniel Wagner


Senior Managing Director at Connecticut Innovations

Photo of Daniel Wagner, Managing Director at Connecticut Innovations

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Connecticut Innovations Managing Director
$150K - $7.0M
CompanyStageDateRound SizeTotal Raised
Tangen Biosciences
Series AJun 2019$9M
New Haven Pharmaceuticals
Series BOct 2014$12M
Series AOct 2012$6.5M
P2 Science
Series AApr 2014$1M
Seed RoundMay 2013$650K
Seed RoundMar 2013$200K
Venture RoundJan 2014$5M
Co-investors: Sacha Levy (New York Angels), Elon Boms
Series ASep 2013$15M
Co-investors: Jakob Loven (Nextech Invest), Kush Parmar (5am Ventures), Colleen Cuffaro (Canaan Partners), Tim Shannon (Canaan Partners), Liam Ratcliffe (Access Biotechnology), Stephen Squinto (OrbiMed)
Innovatient Solutions
Series AApr 2013$630K
Debt FinancingNov 2012$250K
Co-investors: Matthew Storeygard (Connecticut Innovations)